Emergent BioSolutions (EBS) – Analyst Ratings
-
Benchmark Upgrades Emergent BioSolutions (EBS) to Buy
-
JPMorgan Reinstates Emergent BioSolutions (EBS) at Underweight
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to EBS Stock Lookup